EvidentIQ

We are a leading next generation technology-amplified data science group offering unique eClinical solutions.

Our Mission

​To deliver end to end coverage of the clinical development value chain.

Create value and relevance for our customers, and support patients by enabling development of better treatments more quickly and efficiently. 

Our Vision

To become the market leader within our industry segment and transform into a cutting-edge data science company powered by technology.

Expertise

Our expertise speaks for us

Leveraging more than 50 years of combined experience providing innovative and creative ways to conduct clinical trials we have achieved:

  • 3,500+ studies
  • 500+ RWE Data Science studies
  • 100+ manuscripts, abstracts and posters
  • 90+ successfully submitted studies to FDA/EMA run on group platform
  • Customers in 83 countries

Innovative Driven end-to-end eClinical Solution

Meeting increasing customer
demand across clinical operations and clinical data management needs with a suite of applications within a single integrated cloud platform, including EDC, CTMS, eTMF, eCOA, coding, remote monitoring, RBM, RTSM, Payments and eFeasibility.

Patient Access

A digital CRO with a direct access to 500,000+ patients and caregivers allowing quick turnaround and cost-efficient patient recruitment and engagement. 

No doctor/ investigator/ patient advocacy groups bias in data collection.

Geographical Reach

In-country patient communities platform in North America and Western Europe (EU5) and ability to conduct studies at a broader scale (LatAM, Asia...)

Regulatory expertise to support broader geographical studies. 

Expertise in RWE Design

An agile and top-notch scientists' team with strong expertise to support innovative methodology and statistical design. 

Data Science

Proprietary tools specifically designed to support our projects. 

In-house team able to quickly develop, adapt, and monitor. 

Fast, Flexible, and Focused Services

Fast, flexible and focused services ranging from ‘full service’ to ‘do-it-yourself’. Select the services you require and create the ideal mix of professional study setup, consulting and training services to meet your specific needs.

TRUSTED BY THE WORLD’S LEADING COMPANIES

Andreas Weber
Lewis Baird
Manuel Neukum
Michael Chekroun
Falk Bielesch

Andreas Weber

CEO

Andreas brings in more than 20 years of industry experience and looks back on a career with top management positions at ERT, Bioclinica and Oracle Health Sciences.

Lewis Baird

CCO

Lewis established and led the European commercial team at Medrio. Prior to Medrio, Lewis held commercial leadership roles at DataTrial, Biorasi and Quintiles.

Manuel Neukum

COO

Manuel has 10 years of experience in the industry and a solid background in Computer Science as well as in Business Administration and Leadership.

Michael Chekroun

CSTO

Michael founded Carenity and has been in the pharmaceutical industry for more than 10 years. He brings in 20 years of experience in strategic consulting, mergers and acquisitions.

Falk Bielesch

CFO

Falk brings a broad range of expertise in Corporate Finance, Strategy Consulting and General Management. He has worked in various positions at JPMorgan, The Boston Consulting Group and recently was co-founder and CFO of a leading German advertising technology company.

Top level management

Andreas Weber

Andreas Weber

CEO

View BIO
Lewis Baird

Lewis Baird

CCO

View BIO
Manuel Neukum

Manuel Neukum

COO

View BIO
Michael Chekroun

Michael Chekroun

CSTO

View BIO
Falk Bielesch

Falk Bielesch

CFO

View BIO

Articles

XClinical, part of the EvidentIQ Group, welcomes the German Cancer Research Center as a new customer.

Success Stories

7 Dec 2021

XClinical, part of the EvidentIQ Group, welcomes the German Cancer Research Center as a new customer.

Researching for a life without cancer with Marvin, our eClinical software solution for clinical trials. The German Cancer Research Center (DKFZ), based in Heidelberg, is one of the largest oncological research institutions in Europe. The mission of the DKFZ “Research for a life without cancer” is intended to help understand the reasons and mechanisms behind […]

eConsent – Improve trial participants experience by meeting them where they are

Webinars

22 Nov 2021

eConsent – Improve trial participants experience by meeting them where they are

Looking for a way to digitize the Informed Consent process and facilitate your clinical trials? On November 18th our eConsent webinar took place. We showed you how EvidentIQ eConsent improves trial participants experience by meeting them where they are. It enables the improved quality and efficiency of clinical trials through insight into the patient experience, […]

The expanding role of Real-world Evidence in early clinical development

News

17 Nov 2021

The expanding role of Real-world Evidence in early clinical development

Why collecting Real World Data is important to optimize clinical trials and get new medical product approved?  In clinical development, the traditional approach to demonstrate efficacy and safety of a new drug has always been in performing the traditional Randomized Clinical Trials (RCT) programs since this is considered by Regulatory Agencies as the best compromise to get sufficient, well-structured data from a subgroup of the […]

We are

0+

employees

0+

years of industry
expertise

0

spoken
languages

0

offices
worldwide

Get a Demo

Let us show you how we can help you. 

Get a Quote

Discover a solution tailored to your needs and budget.

Get a Meeting

Let's start a new project together!

Let’s Start a conversation

Ready to discover how our platform and its suite of applications can meet your needs?

    Success Stories

    Explore

    White Papers

    Explore

    References

    Explore

    We use cookies to personalize content and ads, provide social media features, and analyze traffic to our website. Our partners may combine this information with other data they have provided to you or collected from your use of the services. Because we value your privacy, we hereby request your permission to use the following technologies. You may change / revoke your consent later at any time by clicking on the settings in the lower left corner of the page.

    Please note that according to a recent ruling by the European Court of Justice (ECJ), there is no adequate level of data protection in the USA and therefore a risk to the protection of your data. For example, under certain conditions, your data may be processed by US authorities for control and monitoring purposes. In addition, we currently refer to Art. 49 GDPR with regard to the legal basis for the transfer of data. After implementation of the new EU standard data protection clauses, these will constitute the legal basis for data transfer to third countries.

    OK